New developments in selective cholesteryl ester uptake

Current Opinion in Lipidology

Volumn 24, Issue 5, 2013, Pages 386-392

  Meyer, Jason M ^a   Graf, Gregory A ^a   Van Der Westhuyzen, Deneys R ^a,b  

^a LEXINGTON VA MEDICAL CENTER   (United States)

^b Departments of Internal Medicine and Molecular and Cellular Biochemistry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CHOLESTEROL ESTER; FARNESOID X RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH DENSITY LIPOPROTEIN RECEPTOR; MICRORNA; MICRORNA 223;

BILE SECRETION; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DIABETES MELLITUS; FOAM CELL; GENE TARGETING; HUMAN; INTRACELLULAR TRANSPORT; LIPID LIVER LEVEL; LIPID TRANSPORT; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALIA; MUS;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; CHOLESTEROL ESTERS; DIABETES MELLITUS; HUMANS; LIPOPROTEINS; LIVER; MACROPHAGES; MICE; MICRORNAS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SCAVENGER RECEPTORS, CLASS B;

EID: 84883755352     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283638042     Document Type: Review

References (65)

1. Stein Y, Dabach Y, Hollander G, et al. Metabolism of HDL-cholesteryl ester in the rat, studied with a nonhydrolyzable analog, cholesteryl linoleyl ether. Biochim Biophys Acta 1983; 752:98-105
2. Glass C, Pittman RC, Weinstein DB, Steinberg D. Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: Selective delivery of cholesterol ester to liver, adrenal, and gonad. Proc Natl Acad Sci U S A 1983; 80:5435-5439
3. Pittman RC, Knecht TP, Rosenbaum MS, Taylor CA Jr. A nonendocytotic mechanism for the selective uptake of high density lipoprotein-Associated cholesterol esters. J Biol Chem 1987; 262:2443-2450
4. Rinninger F, Jaeckle S, Pittman RC. A pool of reversibly cell-Associated cholesteryl esters involved in the selective uptake of cholesteryl esters from high-density lipoproteins by Hep G2 hepatoma cells. Biochim Biophys Acta 1993; 1166:275-283
5. Krieger M. Charting the fate of the 'good cholesterol': Identification and characterization of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem 1999; 68:523-558
6. Rigotti A, Trigatti BL, Penman M, et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci U S A 1997; 94:12610-12615
7. Vergeer M, Korporaal SJ, Franssen R, et al. Genetic variant of the scavenger receptor BI in humans. N Engl J Med 2011; 364:136-145
8. Brunham LR, Tietjen I, Bochem AE, et al. Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans. Clin Genet 2011; 79:575-581
9. Chadwick AC, Sahoo D. Functional genomics of the human high-density lipoprotein receptor scavenger receptor BI: An old dog with new tricks. Curr Opin Endocrinol Diabetes Obes 2013; 20:124-131
10. Hoekstra M, van der Sluis RJ, Van Eck M, Van Berkel TJ. Adrenalspecific scavenger receptor BI deficiency induces glucocorticoid insufficiency and lowers plasma very-low-density and low-density lipoprotein levels in mice. Arterioscler Thromb Vasc Biol 2013; 33: E39-e46
11. Hu J, Zhang Z, Shen WJ, Azhar S. Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones. Nutr Metab (Lond) 2010; 7:47
12. Rigotti A, Miettinen HE, Krieger M. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr Rev 2003; 24:357-387
13. Gu X, Trigatti B, Xu S, et al. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J Biol Chem 1998; 273:26338-26348
14. Rodrigueza WV, Thuahnai ST, Temel RE, et al. Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters from high density lipoprotein to adrenal cells. J Biol Chem 1999; 274:20344-20350
15. Papale GA, Nicholson K, Hanson PJ, et al. Extracellular hydrophobic regions in scavenger receptor BI play a key role in mediating HDL-cholesterol transport. Arch Biochem Biophys 2010; 496:132-139
16. Harder CJ, Vassiliou G, McBride HM, McPherson R. Hepatic SR-BI-mediated cholesteryl ester selective uptake occurs with unaltered efficiency in the absence of cellular energy. J Lipid Res 2006; 47:492-503
17. Knecht TP, Pittman RC. A plasma membrane pool of cholesteryl esters that may mediate the selective uptake of cholesteryl esters from high-density lipoproteins. Biochim Biophys Acta 1989; 1002:365-375
18. Graf GA, Connell PM, van der Westhuyzen DR, Smart EJ. The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol ethers into caveolae. J Biol Chem 1999; 274:12043-12048
19. Sun B, Eckhardt ER, Shetty S, et al. Quantitative analysis of SR-BI-dependent HDL retroendocytosis in hepatocytes and fibroblasts. J Lipid Res 2006; 47:1700-1713
20. Kraemer FB, Shen WJ, Harada K, et al. Hormone-sensitive lipase is required for high-density lipoprotein cholesteryl ester-supported adrenal steroidogenesis. Mol Endocrinol 2004; 18:549-557
21. Vinals M, Xu S, Vasile E, Krieger M. Identification of the N-linked glycosylation sites on the high density lipoprotein (HDL) receptor SR-BI and assessment of their effects on HDL binding and selective lipid uptake. J Biol Chem 2003; 278:5325-5332
22. Sahoo D, Peng Y, Smith JR, et al. Scavenger receptor class B, type I (SR-BI) homo-dimerizes via its C-Terminal region: Fluorescence resonance energy transfer analysis. Biochim Biophys Acta 2007; 1771:818-829
23. Gaidukov L, Nager AR, Xu S, et al. Glycine dimerization motif in the N-Terminal transmembrane domain of the high density lipoprotein receptor SR-BI required for normal receptor oligomerization and lipid transport. J Biol Chem 2011; 286:18452-18464
24. Papale GA, Hanson PJ, Sahoo D. Extracellular disulfide bonds support scavenger receptor class B type I-mediated cholesterol transport. Biochemistry 2011; 50:6245-6254
25. Hu J, Zhang Z, Shen WJ, et al. Differential roles of cysteine residues in the cellular trafficking, dimerization, and function of the high-density lipoprotein receptor, SR-BI. Biochemistry 2011; 50:10860-10875
26. Guo L, Chen M, Song Z, et al. C323 of SR-BI is required for SR-BI-mediated HDL binding and cholesteryl ester uptake. J Lipid Res 2011; 52:2272-2278
27. Yu M, Lau TY, Carr SA, Krieger M. Contributions of a disulfide bond and a reduced cysteine side chain to the intrinsic activity of the high-density lipoprotein receptor SR-BI. Biochemistry 2012; 51:10044-10055
28. Kocher O, Birrane G, Yesilaltay A, et al. Identification of the PDZ3 domain of the adaptor protein PDZK1 as a second, physiologically functional binding site for the C terminus of the high density lipoprotein receptor scavenger receptor class B type I. J Biol Chem 2011; 286:25171-25186
29. Kocher O, Krieger M. Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI. Curr Opin Lipidol 2009; 20:236-241
30. Hu Z, Hu J, Zhang Z, et al. Regulation of expression and function of scavenger receptor class B, type I (SR-BI) by Na-/H- exchanger regulatory factors (NHERFs). J Biol Chem 2013; 288:11416-11435
31. Saddar S, Carriere V, Lee WR, et al. Scavenger receptor class B type I is a plasma membrane cholesterol sensor. Circ Res 2013; 112:140-151
32. Zahid MN, Turek M, Xiao F, et al. The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis Cvirus infection and viral dissemination. Hepatology 2013; 57:492-504
33. Mineo C, Shaul PW. Functions of scavenger receptor class B, type I in atherosclerosis. Curr Opin Lipidol 2012; 23:487-493
34. Hoekstra M, Van Eck M, Korporaal SJ. Genetic studies in mice and humans reveal new physiological roles for the high-density lipoprotein receptor scavenger receptor class B type I. Curr Opin Lipidol 2012; 23:127-132
35. Zhang Y, Da Silva JR, Reilly M, et al. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest 2005; 115:2870-2874
36. Rosenson RS, Brewer HB Jr, Davidson WS, et al. Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport. Circulation 2012; 125:1905-1919
37. Temel RE, Brown JM. Biliary and nonbiliary contributions to reverse cholesterol transport. Curr Opin Lipidol 2012; 23:85-90
38. Kozarsky KF, Donahee MH, Rigotti A, et al. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997; 387:414-417
39. Fuchs M, Ivandic B, Muller O, et al. Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI. Hepatology 2001; 33:1451-1459
40. Wiersma H, Gatti A, Nijstad N, et al. Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice. Hepatology 2009; 50:1263-1272
41. Dikkers A, de Boer JF, Annema W, et al. Scavenger receptor BI and ABCG5/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice. Hepatology 2013
42. Silver DL, Wang N, Xiao X, Tall AR. High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J Biol Chem 2001; 276:25287-25293
43. Bennion LJ, Grundy SM. Effects of diabetes mellitus on cholesterol metabolism in man. N Engl J Med 1977; 296:1365-1371
44. Murao K, Yu X, Imachi H, et al. Hyperglycemia suppresses hepatic scavenger receptor class B type I expression. Am J Physiol Endocrinol Metab 2008; 294:E78-E87
45. Lundasen T, Liao W, Angelin B, Rudling M. Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7alpha-hydroxylase (Cyp7a1) in leptin-deficient (ob/ob) mice. J Biol Chem 2003; 278:43224-43228
46. de Boer JF, Annema W, Schreurs M, et al. Type I diabetes mellitus decreases in vivo macrophage-To-feces reverse cholesterol transport despite increased biliary sterol secretion in mice. J Lipid Res 2012; 53:348-357
47. Annema W, Dikkers A, Freark de Boer J, et al. ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma. J Lipid Res 2012; 53:929-940
48. Kontush A, Chapman MJ. Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 2006; 58:342-374
49. Corsetti JP, Gansevoort RT, Bakker SJ, et al. Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein. Metabolism 2012; 61:996-1002
50. Lambert G, Amar MJ, Guo G, et al. The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J Biol Chem 2003; 278:2563-2570
51. Li G, Thomas AM, Williams JA, et al. Farnesoid X receptor induces murine scavenger receptor class B type I via intron binding. PLoS One 2012; 7:e35895
52. Hambruch E, Miyazaki-Anzai S, Hahn U, et al. Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (-/-) mice. J Pharmacol Exp Ther 2012; 343:556-567
53. Hartman HB, Gardell SJ, Petucci CJ, et al. Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/-And apoE-/-mice. J Lipid Res 2009; 50:1090-1100
54. Fuchs M. Nonalcoholic fatty liver disease: The bile acid-Activated farnesoid x receptor as an emerging treatment target. J Lipids 2012; 2012:934396
55. Wang L, Jia XJ, Jiang HJ, et al. MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition. Mol Cell Biol 2013; 33:1956-1964
56. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011; 145:341-355
57. Kruth HS. Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles. Curr Opin Lipidol 2011; 22:386-393
58. Rinninger F, Greten H. High-density lipoprotein particle uptake and selective uptake of high-density lipoprotein-Associated cholesteryl esters by J774 macrophages. Biochim Biophys Acta 1990; 1043:318-326
59. Rinninger F, Deichen JT, Jackle S, et al. Selective uptake of high-density lipoprotein-Associated cholesteryl esters and high-density lipoprotein particle uptake by human monocyte-macrophages. Atherosclerosis 1994; 105:145-157
60. Brundert M, Heeren J, Bahar-Bayansar M, et al. Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BI. J Lipid Res 2006; 47:2408-2421
61. Ji A, Meyer JM, Cai L, et al. Scavenger receptor SR-BI in macrophage lipid metabolism. Atherosclerosis 2011; 217:106-112
62. Meyer JM, Ji A, Cai L, van der Westhuyzen DR. High-capacity selective uptake of cholesteryl ester from native LDL during macrophage foam cell formation. J Lipid Res 2012; 53:2081-2091
63. Wang MD, Kiss RS, Franklin V, et al. Different cellular traffic of LDLcholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathways. J Lipid Res 2007; 48:633-645
64. Wustner D, Mondal M, Tabas I, Maxfield FR. Direct observation of rapid internalization and intracellular transport of sterol by macrophage foam cells. Traffic 2005; 6:396-412
65. Cruz JC, Thomas M, Wong E, et al. Synthesis and biochemical properties of a new photoactivatable cholesterol analog 7,7-Azocholestanol and its linoleate ester in Chinese hamster ovary cell lines. J Lipid Res 2002; 43:1341-1347